Home › Oligomerix Awarded A Grant For Its Alzheimer's Drug Discovery Program Targeting Tau Oligomers From The National Institutes Of Health
 

Keywords :   


Oligomerix Awarded A Grant For Its Alzheimer's Drug Discovery Program Targeting Tau Oligomers From The National Institutes Of Health

2016-05-03 02:45:01| drugdiscoveryonline News Articles

Oligomerix, Inc., a privately held company targeting tau oligomers for developing disease modifying therapeutics for Alzheimer’s disease (AD) and related neurodegenerative disorders, announced recently the receipt of an award for a Direct-to-Phase-II Small Business Innovation Research (SBIR) grant for a two year program for a total of $1.5 M from the National Institutes of Health (NIH), National Institute on Aging (NIA)

Tags: of health program national

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05More people seek help for debts as fee scrapped
17.05Hunt hints at another National Insurance tax cut
17.05Alan Bates rejects second Post Office compensation offer
17.05Severn Trent boss defends multi-million pay packet
17.05Coptis Marks 25th Anniversary
17.05Farm Progress America, May 17, 2024
17.05Farm Progress America, May 17, 2024
17.05China pours billions into crisis-hit property market
More »